Tag Archives: The Stem Cell Blog

A country that punishes drug traffickers with death is investing in medical marijuana – Quartz

Continue reading

2018-01-25 NEWS

Quartz

A country that punishes drug traffickers with death is investing in medical marijuana
Quartz
One of the countries with the world’s harshest drug laws is planning to invest in medicinal pot. Singapore’s National Research Foundation (NRF) this month (Jan. 10) announced that it would develop synthetic cannabinoids, or chemical compounds found in

Continue reading

2018-01-25 NEWS

Christian Post

Gene responsible for mesenchymal stem cells‘ ‘stem-ness’ identified
Science Daily
Mesenchymal stem cells (MSCs) are popular tools for these therapies because they can differentiate into a variety of mature cell types such as bone, fat and cartilage. They also support hematopoiesis — the formation of blood cells — and secrete
Scientists Develop New Method to Create Stem Cells Without Killing Human EmbryosChristian Post

all 10 news articles »

Continue reading

2018-01-25 NEWS

Christian Post

Gene responsible for mesenchymal stem cells‘ ‘stem-ness’ identified
Science Daily
Mesenchymal stem cells (MSCs) are popular tools for these therapies because they can differentiate into a variety of mature cell types such as bone, fat and cartilage. They also support hematopoiesis — the formation of blood cells — and secrete
Scientists Develop New Method to Create Stem Cells Without Killing Human EmbryosChristian Post

all 10 news articles »

Continue reading

2018-01-24 NEWS

Endpoints News

Spark licenses blindness gene therapy rights outside US to Novartis
Reuters
In a statement, Spark said the deal leverages Novartis’ “large, existing commercial and medical infrastructure in ophthalmology, as well as its commitment to commercializing genetic-based medicines.” Novartis, which sells opthalmology drugs including
Novartis steps in to grab ex-US rights to pioneering gene therapy Luxturna with $170M dealEndpoints News
Novartis strikes $170m deal for ex-US rights to gene therapy for blindnessFinancial Times
Novartis Pays Spark $105M Up Front for Gene Therapy Rights Outside USXconomy
Philly.com (blog) –Labiotech.eu (blog) –pharmaphorum
all 25 news articles »
Continue reading

2018-01-24 NEWS

The San Diego Union-Tribune

Sorrento Therapeutics expands cancer treatment manufacturing on East Coast
The San Diego Union-Tribune
Located in Providence, Rhode Island at Roger Williams Medical Center, the new center, together with Sorrento’s San Diego CAR T facility, allows the company to make treatments for about 300 patients a year. The company has one CAR T product in clinical

and more »

Continue reading

2018-01-24 NEWS

Endpoints News

Novartis steps in to grab ex-US rights to pioneering gene therapy Luxturna with $170M deal
Endpoints News
Just days ahead of Vas Narasimhan’s jump into the CEO’s spot, Novartis has swooped in with a $170 million deal to grab ex-US rights on Spark Therapeutics’ Luxturna, the first true gene therapy to get a US approval. The pharma giant is paying $105
Novartis strikes $170m deal for ex-US rights to gene therapy for blindnessFinancial Times
Novartis exclusively licenses first ophthalmology gene therapy in all markets outside the US, a milestone for GlobeNewswire (press release)
Spark licenses blindness gene therapy rights outside US to NovartisReuters
Nasdaq
all 5 news articles »